researcher comment: ribociclib efficacy for visceral metastases | denise yardley
Published 4 years ago • 295 plays • Length 8:55Download video MP4
Download video MP3
Similar videos
-
1:58
dr. yardley on endocrine therapy plus cdk4/6 inhibitors in breast cancer with visceral metastases
-
1:11
using ribociclib in the first-line setting
-
2:19
dr. yardley on importance of tailoring treatment to breast cancer subtypes
-
8:05
dr. denise a. yardley and sue friedman of force talk #metastaticbreastcancer treatment on #conversat
-
0:43
dr. yardley shares insight on the impact of biosimilars
-
2:53
meet dr. erica v. bloomquist, breast cancer surgeon, memorial cancer institute
-
3:08
adding ribociclib to endocrine therapy shows an improvement in invasive dfs in hr /her2 bc patients
-
1:42
dr. yardley discusses enzalutamide in hr breast cancer
-
3:34
erß expression predicts breast cancer risk in hyperplasia
-
2:53
breast cancer treatment extends live | dr. denise yardley & sue friedman | dailyflash
-
1:19
dr. yardley offers advice to community oncologists on managing patients
-
1:35
an overview of the tnacity trial in tnbc
-
0:56
dr. yardley on unmet need for patients with her2 breast cancer
-
14:10
tmbs e99: dr denise yardley, good news for cancer patients
-
1:36
dr. denise a. yardley on the hermione trial in her2 breast cancer
-
1:59
the role of enzalutamide in hr advanced breast cancer
-
7:23
study of ribociclib and pdr001 in hr metastatic breast cancer
-
8:41
renowned oncologist dr. denise yardley talks breast cancer myths, misconceptions, treatment options